ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

DOW JONES NEWSWIRES Republicans on the House Energy and Commerce Committee are seeking information from several large drug companies about their agreements with the Obama administration during the formation of the health-care reform law, Bloomberg News reported Friday, citing three people familiar with the talks. One of the people said the Republicans turned to direct negotiations with the companies after trade group Pharmaceutical Research and Manufacturers of America didn't cooperate, Bloomberg reported. The committee is seeking documents and other information from Pfizer Inc. (PFE), Merck & Co. (MRK), Amgen Inc. (AMGN), Abbott Laboratories (ABT) and AstraZeneca PLC (AZN), Bloomberg reported. Rep. Michael Burgess (R., Texas) told Bloomberg that "this has been like pulling teeth, trying to get information." A spokesman for PhRMA said "we have been cooperating with the committee on an ongoing basis since the investigation began," Bloomberg reported. Full story at http://www.bloomberg.com/news/2012-05-04/obama-deal-with-drugmakers-said-to-be-probed-by-house.html -Dow Jones Newswires; 212-416-2900

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
04/18/201511:04:02The 3 Best Stocks for Investing in Cholesterol Drugs
04/16/201516:05:00Amgen Announces Webcast Of 2015 First Quarter Financial Results
04/16/201507:34:40Amgen's "Overweight" Rating Reiterated at Piper Jaffray (AMGN)
04/15/201519:52:41Correction to Corlanor Article
04/15/201518:40:08FDA Approves Amgen's Heart-Failure Drug Corlanor -- Update
04/15/201518:31:09FDA Approves Amgen's Heart-Failure Drug Corlanor
04/15/201518:25:44FDA Approves Amgen's Heart-Failure Drug Corlanor
04/15/201517:04:00FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization...
04/15/201508:59:033 Biotech Stocks That May Disappear Before 2020
04/13/201516:06:44Additional Proxy Soliciting Materials (definitive) (defa14a)
04/13/201510:42:08Radius Health: Flying Under The Radar With An Exceptional Pipeline
04/11/201515:02:0310 Largest Companies by Market Cap in Biotech
04/11/201514:02:03How Amgen Could Side-Step The Sting of Patent Expiration
04/11/201503:51:07Immunotherapy: Unleashing The Immune System To Decimate Cancer
04/09/201517:59:09Why Investors Shouldn't Worry About Explosive New Drug Pricing:...
04/08/201513:19:07Chasing - And Surviving - Today's Income Storm
04/06/201508:01:17Could Celgene Corporation Muscle Its Way Past Amgen Inc.?
04/06/201507:20:30Expanded indication for Amgen's Vectibix cleared in Europe
04/06/201505:00:00European Commission Approves Amgen's Vectibix® (panitumumab...
04/05/201509:52:02Can This Pharma Go From Good to Great?

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad